Anthony Priestley

An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN‐D0501 in healthy subjects

Patrick Round, Anthony Priestley, Jan Robinson · British Journal of Clinical Pharmacology · 2011 · 65 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers

Alain Munafo, Anthony Priestley, Ivan Nestorov et al. · European Journal of Clinical Pharmacology · 2007 · 60 citations

Medicine, Pharmacokinetics, Pharmacology +4

Pharmacokinetics of recombinant human growth hormone administered by cool.click™ 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle

Chris Brearley, Anthony Priestley, James Leighton-Scott et al. · BMC Clinical Pharmacology · 2007 · 34 citations · Full text

Pharmacy, Endocrinology, Pharmacokinetics +15

A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single Enantiomer (+)-Mefloquine Compared with Racemic Mefloquine in Healthy Persons

Robert Tansley, Julie Lotharius, Anthony Priestley et al. · American Journal of Tropical Medicine and Hygiene · 2010 · 20 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Absolute Oral Bioavailability of Almorexant, a Dual Orexin Receptor Antagonist, in Healthy Human Subjects

Matthias Hoch, Petra Hoever, Jochen Zisowsky et al. · Pharmacology · 2012 · 14 citations

Pharmacy, Pharmacokinetics, Pharmacology +17